Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Santantonio

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Current Pharmaceutical Design|July 29, 2004
Treatment of acute hepatitis CT Santantonio
Minerva Gastroenterologica E Dietologica|March 1, 1995
[The sequencing of viral genomes]T Santantonio
Current Pharmaceutical Design|August 5, 2008
Therapy of acute hepatitis C: a review of literatureT Santantonio, M Fasano
Journal of Hepatology|April 6, 1999
Lamivudine is safe and effective in fulminant hepatitis BT Santantonio, M Mazzola, G Pastore
The Italian Journal of Gastroenterology|June 1, 1995
Appearance of HBV mutants during chronic infectionT Santantonio, G Pastore, H Will
Bollettino Della Societa Italiana Di Biologia Sperimentale|July 30, 1983
[Evaluation of free and IgG-bound components of e antigen (HBeAg) in acute virus B hepatitis]T Santantonio, E Albore, G Angarano, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|May 30, 1984
[Immunoenzyme determination of IgA specific anti-HAV in the serological diagnosis of hepatitis A]F Trotta, G Angarano, T Santantonio, et al.
Lancet (London, England)|November 23, 1996
Ciprofloxacin for treating choleraP Maggi, S Carbonara, T Santantonio, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1982
[Radioimmunological determination of HAV and anti-HAV IgA in the feces of patients with acute type-A hepatitis]G Angarano, S Coppola, V Frappampina, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1985
Serum IgA anti-hepatitis A virus as detected by enzyme-linked immunosorbent assay. Diagnostic significance in patients with acute and protracted hepatitis AG Angarano, F Trotta, L Monno, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Current Pharmaceutical Design|July 29, 2004
Treatment of acute hepatitis CT Santantonio
Minerva Gastroenterologica E Dietologica|March 1, 1995
[The sequencing of viral genomes]T Santantonio
Current Pharmaceutical Design|August 5, 2008
Therapy of acute hepatitis C: a review of literatureT Santantonio, M Fasano
Journal of Hepatology|April 6, 1999
Lamivudine is safe and effective in fulminant hepatitis BT Santantonio, M Mazzola, G Pastore
The Italian Journal of Gastroenterology|June 1, 1995
Appearance of HBV mutants during chronic infectionT Santantonio, G Pastore, H Will
Bollettino Della Societa Italiana Di Biologia Sperimentale|July 30, 1983
[Evaluation of free and IgG-bound components of e antigen (HBeAg) in acute virus B hepatitis]T Santantonio, E Albore, G Angarano, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|May 30, 1984
[Immunoenzyme determination of IgA specific anti-HAV in the serological diagnosis of hepatitis A]F Trotta, G Angarano, T Santantonio, et al.
Lancet (London, England)|November 23, 1996
Ciprofloxacin for treating choleraP Maggi, S Carbonara, T Santantonio, et al.
Bollettino Dell'Istituto Sieroterapico Milanese|January 1, 1982
[Radioimmunological determination of HAV and anti-HAV IgA in the feces of patients with acute type-A hepatitis]G Angarano, S Coppola, V Frappampina, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1985
Serum IgA anti-hepatitis A virus as detected by enzyme-linked immunosorbent assay. Diagnostic significance in patients with acute and protracted hepatitis AG Angarano, F Trotta, L Monno, et al.
Pageof 9